Phase II trial of nivolumab in combination with talazoparib in patients with unresectable or metastatic melanoma and mutations in BRCA or BRCA-ness

被引：0
|
作者：
Isaacs, James
Sussman, Tamara A.
Kennedy, Lucy B.
Arbesman, Joshua
Gastman, Brian
Zhou, Millennia
Zabor, Emily
Diaz-Montero, Claudia
Ko, Jennifer
Funchain, Pauline
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-CT261
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT261
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PHASE-II TRIAL OF BISANTRENE IN PATIENTS WITH METASTATIC MELANOMA
    MACKEL, C
    MEYSKENS, FL
    ALBERTS, DS
    CANCER TREATMENT REPORTS, 1986, 70 (08): : 1037 - 1038
  • [32] A phase II trial of arsenic trioxide in patients with metastatic melanoma
    Kim, KB
    Bedikian, AY
    Camacho, LH
    Papadopoulos, NE
    McCullough, C
    CANCER, 2005, 104 (08) : 1687 - 1692
  • [33] Phase II trial of imatinib mesylate in patients with metastatic melanoma
    Kim, K. B.
    Eton, O.
    Davis, D. W.
    Frazier, M. L.
    McConkey, D. J.
    Diwan, A. H.
    Papadopoulos, N. E.
    Bedikian, A. Y.
    Camacho, L. H.
    Ross, M. I.
    Cormier, J. N.
    Gershenwald, J. E.
    Lee, J. E.
    Mansfield, P. F.
    Billings, L. A.
    Ng, C. S.
    Charnsangavej, C.
    Bar-Eli, M.
    Johnson, M. M.
    Murgo, A. J.
    Prieto, V. G.
    BRITISH JOURNAL OF CANCER, 2008, 99 (05) : 734 - 740
  • [34] A phase II trial of tazemetostat for patients with unresectable or metastatic epithelioid sarcoma (TAZETTA trial)
    Kita, Shosuke
    Shimoi, Tatsunori
    Komine, Keigo
    Ando, Masashi
    Ariyama, Hiroshi
    Okita, Natsuko
    Sadachi, Ryo
    So, Naoko
    Azuma, Satoshi
    Kazumi, Yuki
    Yonemori, Kan
    ANNALS OF ONCOLOGY, 2023, 34 : S1392 - S1392
  • [35] Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma
    Camacho, Luis H.
    Antonia, Scott
    Sosman, Jeffrey
    Kirkwood, John M.
    Gajewski, Thomas F.
    Redman, Bruce
    Pavlov, Dmitri
    Bulanhagui, Cecile
    Bozon, Viviana A.
    Gomez-Navarro, Jesus
    Ribas, Antoni
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1075 - 1081
  • [36] A Phase 1 Clinical Trial of Ipilimumab, Nivolumab and Radiation Therapy for Patients with Metastatic Melanoma
    Barker, C. A.
    Postow, M. A.
    Goldman, D. A.
    Panageas, K. S.
    Halpenny, D.
    McCabe, D.
    Macri, M.
    Schwarzenberger, P.
    Ricciardi, T.
    Ryan, A.
    Venhaus, R.
    Knox, S. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S78 - S79
  • [37] MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA
    ATKINS, MB
    OBOYLE, KR
    SOSMAN, JA
    WEISS, GR
    MARGOLIN, KA
    ERNEST, ML
    KAPPLER, K
    MIER, JW
    SPARANO, JA
    FISHER, RI
    ECKARDT, JR
    PEREIRA, C
    ARONSON, FR
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (08) : 1553 - 1560
  • [38] Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial
    Wierzbicka-Hainaut, Ewa
    Sassolas, Bruno
    Mourey, Laurent
    Guillot, Bernard
    Bedane, Christophe
    Guillet, Gerard
    Tourani, Jean Marc
    MELANOMA RESEARCH, 2010, 20 (02) : 141 - 146
  • [39] Phase II study of pazopanib in combination with paclitaxel in patients with metastatic melanoma
    Fruehauf, John P.
    El-Masry, Monica
    Osann, Katherine
    Parmakhtiar, Basmina
    Yamamoto, Maki
    Jakowatz, James G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 353 - 360
  • [40] Phase II study of pazopanib in combination with paclitaxel in patients with metastatic melanoma
    John P. Fruehauf
    Monica El-Masry
    Katherine Osann
    Basmina Parmakhtiar
    Maki Yamamoto
    James G. Jakowatz
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 353 - 360
12345